Literature DB >> 20062627

Incredibly late thromboses in first generation drug eluting stents: a case series.

Zakir Shaik1, Khaja S Mohammed, Adnan Siddiqi, Ilyas Mohammed, Timothy A Shapiro, Thomas P Phiambolis.   

Abstract

BACKGROUND: The drug-eluting stents have decreased the incidence of instent restenosis compared to bare metal stents. But, the incidence of late and very late stent thrombosis has increased with the drug-eluting stents. CASE
PRESENTATION: We are here, reporting three cases of incredibly late instent thrombosis, each one occurring after more than 50 months of drug-eluting stent placement.
CONCLUSION: The occurrence of stent thrombosis as late as 5 years has been reported in literature. This highlights the importance that there may be no limit to the time duration to the occurrence of very late stent thrombosis and dual antiplatelet therapy with aspirin and clopidogrel may have to be continued indefinitely in patients with drug-eluting stents.

Entities:  

Year:  2009        PMID: 20062627      PMCID: PMC2803967          DOI: 10.1186/1757-1626-2-9303

Source DB:  PubMed          Journal:  Cases J        ISSN: 1757-1626


  15 in total

1.  Late angiographic stent thrombosis (LAST) events with drug-eluting stents.

Authors:  Andrew T L Ong; Eugène P McFadden; Evelyn Regar; Peter P T de Jaegere; Ron T van Domburg; Patrick W Serruys
Journal:  J Am Coll Cardiol       Date:  2005-06-21       Impact factor: 24.094

2.  Correlates and long-term outcomes of angiographically proven stent thrombosis with sirolimus- and paclitaxel-eluting stents.

Authors:  Pramod K Kuchulakanti; William W Chu; Rebecca Torguson; Patrick Ohlmann; Seung-Woon Rha; Leonardo C Clavijo; Sang-Wook Kim; Ahn Bui; Natalie Gevorkian; Zhenyi Xue; Kimberly Smith; Jana Fournadjieva; William O Suddath; Lowell F Satler; Augusto D Pichard; Kenneth M Kent; Ron Waksman
Journal:  Circulation       Date:  2006-02-20       Impact factor: 29.690

3.  Pathology of drug-eluting stents in humans: delayed healing and late thrombotic risk.

Authors:  Michael Joner; Aloke V Finn; Andrew Farb; Erik K Mont; Frank D Kolodgie; Elena Ladich; Robert Kutys; Kristi Skorija; Herman K Gold; Renu Virmani
Journal:  J Am Coll Cardiol       Date:  2006-05-05       Impact factor: 24.094

Review 4.  Analysis of 36 reported cases of late thrombosis in drug-eluting stents placed in coronary arteries.

Authors:  Ramin Artang; Robert S Dieter
Journal:  Am J Cardiol       Date:  2007-02-23       Impact factor: 2.778

5.  Analysis of 14 trials comparing sirolimus-eluting stents with bare-metal stents.

Authors:  Adnan Kastrati; Julinda Mehilli; Jürgen Pache; Christoph Kaiser; Marco Valgimigli; Henning Kelbaek; Maurizio Menichelli; Manel Sabaté; Maarten J Suttorp; Dietrich Baumgart; Melchior Seyfarth; Matthias E Pfisterer; Albert Schömig
Journal:  N Engl J Med       Date:  2007-02-12       Impact factor: 91.245

6.  Safety and efficacy of sirolimus- and paclitaxel-eluting coronary stents.

Authors:  Gregg W Stone; Jeffrey W Moses; Stephen G Ellis; Joachim Schofer; Keith D Dawkins; Marie-Claude Morice; Antonio Colombo; Erick Schampaert; Eberhard Grube; Ajay J Kirtane; Donald E Cutlip; Martin Fahy; Stuart J Pocock; Roxana Mehran; Martin B Leon
Journal:  N Engl J Med       Date:  2007-02-12       Impact factor: 91.245

7.  Safety of coronary sirolimus-eluting stents in daily clinical practice: one-year follow-up of the e-Cypher registry.

Authors:  Philip Urban; Anthony H Gershlick; Giulio Guagliumi; Philippe Guyon; Chaim Lotan; Joachim Schofer; Ashok Seth; J Eduardo Sousa; William Wijns; Claude Berge; Monika Deme; Hans-Peter Stoll
Journal:  Circulation       Date:  2006-03-13       Impact factor: 29.690

8.  Incidence and predictors of drug-eluting stent thrombosis during and after discontinuation of thienopyridine treatment.

Authors:  Flavio Airoldi; Antonio Colombo; Nuccia Morici; Azeem Latib; John Cosgrave; Lutz Buellesfeld; Erminio Bonizzoni; Mauro Carlino; Ulrich Gerckens; Cosmo Godino; Gloria Melzi; Iassen Michev; Matteo Montorfano; Giuseppe Massimo Sangiorgi; Asif Qasim; Alaide Chieffo; Carlo Briguori; Eberhard Grube
Journal:  Circulation       Date:  2007-07-30       Impact factor: 29.690

9.  Extremely late drug-eluting stent thrombosis: 2037 days after deployment.

Authors:  Jamie Layland; Christine Jellis; Robert Whitbourn
Journal:  Cardiovasc Revasc Med       Date:  2009 Jan-Mar

10.  Very late stent thrombosis after drug-eluting stent implantation in a patient without aspirin and clopidogrel resistance.

Authors:  Sang Yup Lim; Ki Seok Kim; Seung Jae Joo; Myung Ho Jeong
Journal:  J Korean Med Sci       Date:  2008-06       Impact factor: 2.153

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.